OTC: CHGCY - Chugai Pharmaceutical Co., Ltd.

Yield per half year: -7.66%
Dividend yield: 0.00%
Sector: Healthcare

Chugai Pharmaceutical Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
14.77 35.48 -58.36% 13.76 +7.34%
P/S 4.89 3.31 47.87%
P/BV 3.01 3.11 -3.39%
P/FCF 17.36 14.05 23.58%
Ev/Ebitda 9.56 11.99 -20.28%
Ev/S 4.43 2.76 60.71%
Ev/FCF 13.19 12.58 4.84%
E/P 0.0568 1.47 -96.13%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
46.32 25.06 84.84% 43.4 +6.74%
ROE 0.3353 12.29 -97.27%
ROA 0.2821 5.97 -95.28%
ROIC 34.85 15.56 123.99%
ROS 33.09 12.34 168.23%
ROCE 21.64 14.8 46.18%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
4/10
3.47 6.19 -44% 2.41 +43.99%
Nеt Debt/Ebitda -0.9974 -3.89 -74.39%
Debt/Ratio 0.8513 0.2205 286.01%
Debt/Equity 0.1614 1.01 -83.98%
Debt/Net Income 4.86 16.9 -71.27%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.55 -100% 1.91 -100%
Number of years of dividend growth 1 1.38 -27.55%
DSI 0.7143 0.7718 -7.45%
Average dividend growth -1715.78 -260.86 557.73%
Average percentage for 5 years 1.91 2.72 -29.83%
Average percentage for payments 299.08 168.02 78.01%
Difference from average difference in sector -1.55

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-98.96 33.42 -396.11%
Growth impulse Ebitda in 5 years -98.73 26.07 -478.71%
Growth impulse Net Income in 5 years -98.74 27.45 -459.71%
Growth impulse FCF in 5 years -98.09 11.59 -946.33%
Growth impulse EPS in 5 years -42.46 79.86 -153.17%
IP Score
4.54/10

Similar companies

Teligent, Inc.

Astellas Pharma Inc.

Eisai Co., Ltd.

Roche Holding

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription